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Supramolecular aggregates obtained by self-aggregation of ﬁve new cationic amphiphilic CCK8
peptides have been obtained in water solution and characterized for: (i) aggregate structure and
stability; (ii) CCK8 peptide conformation and bioavailability on the external aggregate surface; and
(iii) for their cell binding properties. The cationic amphiphilic CCK8 peptides self-aggregate giving a
combination of liposomal and micelle structures, with radii ranging betweenB60 nm andB90 nm,
and betweenB5 andB10 nm, respectively. The presence of CCK8 peptide well-exposed on the
aggregate surface is demonstrated by ﬂuorescence measurements. Peptide conformation changes in
the ﬁve supramolecular aggregates: the CCK8 conformational behaviour is probably induced by the
presence of three charged lysine residues close to the bioactive peptide sequence. Only aggregates in
which the CCK8 peptide presents a structural arrangement similar to that found for the same
peptide in DPC micelles give promising binding properties to CCK2-R receptors overexpressed
by transfected A431 cells. Chemical modiﬁcations on the CCK8 N-terminus seem to play an
important role in stabilizing the peptide active conformation, either when the peptide derivative
is in monomeric or in aggregate form. For their easy preparation procedures and their binding
properties, supramolecular aggregates based on cationic peptide amphiphiles can be considered
as promising candidates for target selective drug carriers on cancer cells.
1. Introduction
A major goal in current medical treatment is the selective
delivery of drugs and other active compounds directly to a
target tissue.1 This would allow the reduction of undesired
eﬀects on non target organs and the increase of therapeutic
eﬃcacy on the desired tissues. Drug delivery procedures, aimed
at achieving this goal, have been investigated particularly for
the treatment of cancer.2 Several receptors overexpressed on
tumour cells can provide homing properties for therapeutic or
diagnostic molecules containing binding motifs for the speciﬁc
receptor.3,4 Peptides able to recognize in a selective way these
receptors may be exploited to address a simple entity, such as
an anticancer drug, to target cells at higher concentrations
compared to non-target cells.5
A more complex and challenging objective would be to adopt
a similar scheme to deliver peptide-exposing supramolecular
aggregates, such as micelles or liposomes, to a tissue of inter-
est.6,7 Such aggregates could be utilized as nanocarriers for large
amounts of drugs or other substances contained in the inner
cavity or exposed on the external surface of the supramolecular
aggregate.8–10 Examples of target speciﬁc supramolecular aggre-
gates, employed as carriers of drugs or metal complexes, include
micelles and liposomes loaded with poorly soluble anticancer
agents or bearing Gd(III) complexes.11–14 To allow the selective
target of the above described supramolecular aggregates on
cancer cells, it is mandatory that the covering peptide remains
well-exposed on the external surface of the aggregates, preserving
the right conformation for receptor binding. Moreover the
aggregates should have high in vivo stability and the appropriate
size and shape to remain in the blood before target binding.
Recently, we reported the synthesis and the structural
characterization of (C18)2L5CCK8 Peptide Amphiphile (PA) in
isolated or aggregated form. This molecule contains a dioctadecyl
moiety as a hydrophobic segment, a spacer consisting of ﬁve
units of 8-amino-3,6-dioxaoctanoic acid and glycine residue,
and the carboxyl terminal sequence of the peptide hormone
cholecystokinin, CCK8 (Asp-Tyr-Met-Gly-Trp-Met-Asp-Phe-
Amide), as a bioactive hydrophilic peptide.15 (C18)2L5CCK8
is able to self-assemble, spontaneously, in well-ordered nano-
structures in aqueous solution. The reported supramolecular
aggregates based on PA, could be employed for target-selective
delivery of anticancer drugs, such as the cytotoxic doxorubicin
drug, on a biological target, through the bioactive peptide
exposed on the external surface. In fact, the bioactive CCK8
peptide is able to bind, with high aﬃnity, both CCK1-R and
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CCK2-R cholecystokinin receptors over-expressed by cancer cells
in several human tumours.16
In this way the entrapped drug ismainly delivered in proximity
of the tumour, thus reducing the well-expected toxic side eﬀects
on non-target organs. Although short peptides tend to be ﬂexible
in solution,17 CCK8 has been reported to have some inter-
changing turn conformations stabilized in the presence of the
membrane-like surfactant.18 In contrast, (C18)2L5CCK8 PA,
when self-assembled in nanostructures, presents a much more
deﬁned conformation likely due to the interactions of peptide
side chains that remain very close to each other in the nano-
structure hydrophilic shell.19 However, this folding induced by
the aggregation process could represent a trouble in preserving
the peptide biological activity and its accessibility to the interact-
ing receptor. In fact, according to the theory of membrane-bound
pathway, CCK8 needs to assume a pseudo-a-helix conformation
for the interaction with its G-protein coupled receptors.20–24
Here we report a complete characterization of supramolecular
aggregates composed of ﬁve novel amphiphilic peptides based
on CCK8. In these new compounds, reported in Scheme 1,
the hydrophobic and the hydrophilic moieties are unchanged
with respect to (C18)2L5CCK8, while new spacer moieties,
represented by several lysine residues and by a Ahoh linker, are
introduced in order to stabilize peptide conformations that are
able to guarantee receptor binding also in the aggregate forms.
2. Materials and methods
2.1 Chemicals
Protected Na-Fmoc-amino acid derivatives, coupling reagents, and
Rink amide MBHA resin were purchased from Calbiochem-
Novabiochem (Laufelﬁngen, Switzerland). The Fmoc-21-amino-
4,7,10,13,16,19-hexaoxaheneicosanoic acid (Fmoc–Ahoh–OH)
was purchased from Neosystem (Strasbourg, France). The
N,N-dioctadecylsuccinamic acid was synthesized according
to published methods.25 FITC isomer I, BSA, PBS were
purchased from Sigma-Aldrich (Milan, Italy). DMEM, FCS,
L-glutamine were purchase from Lonza (Milano, Italy).
All other chemicals were commercially available from
Sigma-Aldrich or Fluka (Buchs, Switzerland) or LabScan
(Stillorgan, Dublin, Ireland) and were used as received unless
otherwise stated. Preparative RP-HPLCs were carried out
on a LC8 Shimadzu HPLC system (Shimadzu Corporation,
Kyoto, Japan) equipped with a UV lambda-Max Model 481
detector using a Phenomenex (Torrance, CA) C4 (300 A˚,
250  21.20 mm, 5 mm) column eluted with H2O/0.1% TFA
(A) and CH3CN/0.1% TFA (B) from 20% to 95% over
20 minutes at 20 mL min1 ﬂow rate. Purity and identity were
assessed by analytical LC-MS analyses by using Finnigan
Surveyor MSQ single quadrupole electrospray ionization
(Finnigan/Thermo Electron Corporation San Jose, CA),
column: C4-Phenomenex eluted with H2O/0.1% TFA (A)
and CH3CN/0.1% TFA (B) from 20% to 95% over 20 minutes
at 1 mL min1 ﬂow rate. Mass spectra were carried out on a
MALDI-TOF Voyager-DE Perseptive Biosystem (Framing-
ham, MA) apparatus using the a-cyano-4-hydroxycynnamic
acid as the matrix and bovine insulin as the internal reference.
Concentrations of solutions containing peptide surfactant
were determined by absorbance measurement on a UV-vis
Jasco V-5505 spectrophotometer equipped with a Jasco
ETC-505T Peltier temperature controller with a 1 cm quartz
cuvette (Hellma). The monodimensional 1H NMR and
13C-NMR spectra were performed on a Varian (Palo Alto,
CA) 400 MHz spectrometer. Fluorescence spectra were
recorded at room temperature on a Jasco Model FP-750 spectro-
ﬂuorophotometer in 1.0 cmpath length quartz cell. Equal excitation
and emission bandwidths were used throughout experiments, with
a recording speed of 125 nm min1 and automatic selection of the
time constant. Dynamic light scattering measurements were carried
out by miniDAWN TREOS Wyatt Technology (CA, USA).
2.2 Synthesis of C18H37CONHLys–(FITC)CONH2
(C18–FITC)
The ﬂuorescent monomer was synthesized on solid phase using
Rink-amide (MBHA) resin (0.85 mmol g1; 0.2 mmol, 0.235 g)
as the polymeric support. After the swelling of the resin in
3 mL of DMF for 1 h, the Fmoc protecting group was removed
by adding a mixture of piperidine/DMF 30/70. The carboxylic
function of Fmoc–Lys(Mtt)–OH (0.8 mmol, 0.500 g) was
activated by 1 equiv. of PyBop, HOBt and 2 equiv. of
DIPEA in DMF. The solution was added to the resin and
the slurry suspension was stirred for 1 h. The coupling of
the lysine residue was performed twice and after ﬁltration, the
coupling was checked by the Kaiser colorimetric test. The
solution was ﬁltered and the resin washed with three
portions of DMF and three portions of DCM. The Mtt
protecting group was removed by treatment of the resin with
DCM/TIS/TFA (94 : 5 : 1) mixture, stirring for 5 min. This
procedure was repeated several times until the solution became
colorless. The resin was washed three times by DCM and three
times by DMF. Nonadecanoic acid (2 equiv., 0.252 g) was
Scheme 1 Panel A: schematic representation of cationic PAs. The
amino acid sequence of CCK8 peptide is reported by using the one-letter
amino acid code. The hexaoxahene linker (21-amino-4,7,10,13,16,19-
hexaoxaheneicosanoic acid), L, is also reported. Panel B: schematic
representation of C18-FITC.
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coupled under standard conditions (HOBT/PyBop/DIPEA
1/1/2), and the reaction monitored by Kaiser test. Then, after
the removal of N-terminal Fmoc protecting group Fmoc–b-
Ala–OH and FITC were coupled in sequence. The FITC
coupling was performed overnight at room temperature by
using HATU/DIPEA (1/2 with respect to FITC) as activating
agents. The cleavage from the resin and deprotection of the tBu
protecting groups were obtained stirring for 2 h in TFA
containing 2.5% (v/v) water and 2.0% (v/v) TIS as
scavengers at room temperature. The crude product was
slowly precipitated at 0 1C by adding water drop-wise. The
crystalline solid was washed several times with small portions
of cold water. The product was identiﬁed by mass spectra
(electrospray ionization ESI) and NMR spectroscopy.
C18–FITC: MS (ESI+): m/z (%): 886 (100) [M  H+]
1H-NMR (CDCl3/CD3OD 50/50) (chemical shifts in d,
CD3OD as an internal standard 3.55) = [8.4 (d, J = 14 Hz,
1H), 7.90 (s, 1H), 7.41 (d, J=9Hz, 1H), 7.12 (s, 1H), 7.02 (s, 1H),
6.90 (s, 1H), 6.85 (d, J=12Hz, 1H), 6.78 (s, 1H) aromatic signals]
4.75–4.65 (br m, 1H, CH Lysa), 3.65 (t, J = 8 Hz, 2H,
CH2NHCO), 3.4–3.2 (m, CH2 Lyse), 2.60 (t, J = 7 Hz, 2H
CH2CONH), 2.85–2.75 (br m, 6H, CONHCH2), 2.35
(m, COCH2), 2.1–2.0, 2.0–1.9 (br m, 2H, CH2 Lysb), 1.8–1.7
(br m, 2H, CH2 Lysd), 1.7–1.6 (br m, 2H, CH2 Lysg), 1.45–1.40
(m, 32H, CH2), 1.12 (t, J = 6 Hz, 3H, CH3).
13C-NMR (CDCl3/CD3OD 50/50) (chemical shifts in d,
CD3OD as an internal standard 49.3) = 183.0 (COOH), 176.3,
172.3, 172.0 (3CONH2), 155.1, 153.0, 152.2 (3C–O), 138.0, 132.1,
132.0, 130.3, 130.2, 128.0, 126.2, 125.6, 123.0, 122.2, 118.0, 116.0,
113.9, 113.7, 103.7 (15 C aromatic carbon), 53.4 (CH-Lysa), 53.1
(COCH2NH), overlapped (NCH2CH2CO), 45.3 (CH2-Lyse),
40.1, 37.3 (2 CH2CO), 33.6 (CH2-Lysb), 33.1 (CH2-Lysg),
31.8, 31.4–30.4, 27.12, 24.4, 24.0 (15 CH2 aliphatic moiety),
23.7 (CH2-Lysd), 18.5 (CH3CH2), 14.7 (CH3CH2).
2.3 Peptide synthesis
The synthesis of Fmoc–G-CCK8–NH2 peptide was carried out
in solid-phase under the standard Fmoc strategy,26 by using
433A Applied Biosystems automatic synthesizer. Rink-amide
MBHA resin (0.78 mmol g1, 0.7 mmol scale, 0.900 g) was
used. The elongation of peptides was achieved by sequential
addition of Fmoc–AA–OH with PyBOP/HOBt and DIPEA
(1 : 1 : 2) as coupling reagents, in DMF in pre-activation
mode. The mixture was stirred for 1 h and after ﬁltration.
All couplings were performed twice for 1 hour, by using an
excess of 4 equivalents for the single amino acid derivative.
Fmoc deprotections were obtained by 30% solution of
piperidine in DMF. The peptide-resin was shared in
7 reactors (each one containing 0.1 mmol of peptide-resin),
and syntheses were manually brought to a close. Two reactors
were used to obtain the peptide amide derivatives: H-G-CCK8
and H-K-K-K-G-CCK8, while the other ﬁve reactors to obtain
the peptide amphiphiles (PA-[A], PA-[B], PA-[C], PA-[D]
and PA-[E]). Fmoc–Lys(Boc)–OH residues and the Fmoc–
Ahoh–OH linker were coupled manually in DMF by
using an excess of 4 and 2 equivalents, respectively. N,N-
Dioctadecylsuccinamic acid (0.4 mmol, 0.249 g) coupling was
performed twice for 1 h in the DMF/DCM (50/50) mixture.
The lipophilic moiety was activated in situ by the standard
HOBt/PyBop/DIPEA procedure. The cleavage from the resin
and deprotection of the protecting groups were obtained
stirring for 2 h in TFA containing 2.5% (v/v) water and
2.0% (v/v) TIS, as scavengers, at room temperature. The
crude products were slowly precipitated at 0 1C by adding
diethylether drop-wise. The solids were washed several
times with small portions of cold water, and lyophilized.
Puriﬁcation of the crude mixtures was carried out by
RP-HPLC (l = 280 nm). The ﬁnal products were recovered at
a purity higher than 95%, as indicated by LC-MS analysis, and
ﬁnal yields ranged between 20 and 40%. MALDI-TOF mass
spectra conﬁrm the identities of the ﬁve peptide derivatives.
PA-[A]: (C18)2–K-K-K-G-CCK8–NH2: tR = 24.66 min,
(MW = 2107) m/z = 2108
PA-[B]: (C18)2–L-K-K-K-G-CCK8–NH2: tR = 25.38 min,
(MW = 2443) m/z = 2444
PA-[C]: (C18)2–K-L-K-K-G-CCK8–NH2: tR = 25.46 min,
(MW = 2443) m/z = 2444
PA-[D]: (C18)2–K-K-L-K-G-CCK8–NH2: tR = 25.48 min,
(MW = 2443) m/z = 2444
PA-[E]: (C18)2–K-K-K-L-G-CCK8–NH2: tR = 25.32 min,
(MW = 2443) m/z = 2444
H-G-CCK8: tR = 15.26 min, (MW = 1119) m/z = 1120
H-K-K-K-G-CCK8: tR= 13.65 min, (MW=1521)m/z=1522
2.4 Aggregate formulation and DLS characterization
All solutions were prepared by weight, buﬀering the samples at
pH values in 5.0–12.0 range. Three diﬀerent buﬀer solutions
were used: 0.10 M phosphate buﬀer (pH 12.0); 0.10 M HBS
buﬀer (pH 7.0 and 5.0). pH measurements were made by using
pH-meter MeterLab PHM 220. The pH-meter was calibrated
with three standards at pH 4.00, pH 7.00 and pH 10.00. In
most cases the samples to be measured were prepared from
stock solutions. Concentrations of all solutions were
determined by absorbance on a UV-vis Jasco (Easton, MD)
Model 440 spectrophotometer with a path length of 1 cm using
a molar absorptivity (e280) of 6845 M
1 cm1 for CCK8. This
value was calculated according to the Edelhoch method,27
taking into account contributions from tyrosine and
tryptophan present in the primary structure, which amount
to 1215 and 5630 M1 cm1, respectively.28 Fluorescent
aggregates of PA, containing 1% mol mol1 of C18-FITC
ﬂuorescent probe (FITC-PA aggregates), were prepared for
in vitro uptake assays. Conﬁrmation of incorporation of the
ﬂuorescent probe (1%) into the aggregates was obtained by gel
ﬁltration on Sephadex G-50 pre packed columns (Pharmacia
Biotech). For DLS measurements self-assembled aggregates
solution in isotonic HBS solution were prepared at the ﬁnal
concentration of 1  104 M. Samples were centrifuged at
room temperature at 13 000 rpm for 5 min. The measurement
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was performed at 25 1C. Scattered light intensities were
measured at a ﬁxed scattering angle (y = 901). The results
were processed with the program Qels (Wyatt Technology).
2.5 Fluorescence measurements
Critical micellar concentrations of PA aggregates were obtained
by ﬂuorescence spectroscopy. Emission spectra were recorded at
room temperature using a JascoModel FP-750 spectroﬂuorimeter
in 1.0 cm path length quartz cell. Equal excitation and emission
bandwidths were used throughout experiments, with a recording
speed of 125 nm min1 and automatic selection of the time
constant. The CMC were measured by using ANS as the
ﬂuorescent probe. Small aliquots of 1  105 M aggregate
solution, dissolved in 10 mM HEPES at pH 7.0, were added to
a ﬁxed volume (1.00 mL) of ﬂuorophore (1  105 M ANS)
directly in the quartz cell. CMC values were determined by linear
least-squares ﬁtting of the ﬂuorescence emission at 480 nm, upon
excitation at 350 nm versus the amphiphile concentration, as
previously reported.29,30 To analyse the tryptophan ﬂuorescence,
emission spectra were recorded between 290 and 450 nm at an
excitation wavelength of 280 nm. The spectra of PA-[A]–PA-[E]
were collected at a monomer concentration 2.0  104 M in
10mMHEPES at pH 7.0. Fluorescence emission spectra were also
collected for H-G-CCK8 in buﬀered solution and for H-G-CCK8
in the presence of DPC. In these experiments the H-G-CCK8
peptide concentration was 2  104 M, while DPC concentration
was 10 mM and buﬀer was 10 mM HEPES at pH 7.0.
2.6 Circular dichroism measurements
Far-UV CD spectra were recorded from 195 to 260 nm on a
Jasco J-810 spectropolarimeter equipped with a NesLab
RTE111 thermal controller unit using a 1 mm quartz cell
at 25 1C. Circular dichroism measurements were carried out
on solutions containing peptide or peptide amphiphile at
concentrations of 2  104 M at several pH values (5.0, 7.0,
12.0). Solutions of H-K-K-K-G-CCK8 peptide were prepared
in 10 mM HEPES buﬀer at pH 7.0, and in the presence of 20,
40, 60 or 80% of TFE. Other experimental settings were: scan
speed, 10 nm min1; sensitivity, 50 mdeg; time constant, 16 s;
bandwidth, 1 nm. Each spectrum was obtained averaging three
scans, subtracting contributions from other species in solution,
and converting the signal to mean residue ellipticity in units
of deg cm2 dmol1 res1.
2.7 Cell culture and ﬂow cytometry
Cellular uptake of PA aggregates was studied by ﬂow
cytometry on A431 cells overexpressing the CCK2-R by
stable transfection.31 Cells were cultured as an exponential
growing subconﬂuent monolayer on 100 mm plates in DMEM
supplementedwith 10%FCS, 2mML-glutamine and 250 mgmL1
G418 in a humidiﬁed atmosphere containing 5% CO2 at 37 1C.
Cell aliquots (1  105) were incubated at 4 1C in 100 mL ﬁnal
volume. At the end of the incubation, cells were pelleted,
washed, resuspended in PBS/BSA at 400 mL and analyzed
with a ﬂow cytometer equipped with a 488 nm argon laser
(FACScan, Becton Dickinson, CA, USA). A total of 20 000
events per sample were collected. Values of ﬂuorescence
intensity were obtained from histogram statistic of CellQuest
software. For binding experiments, cells were incubated for 1 h
with 226 mM FITC-PA aggregates. The ﬂuorescence intensity
of cells treated with diﬀerent unlabeled aggregates was
comparable to untreated cells. Therefore, cells treated
with PA-[C] were used as negative control. For competitive
binding experiments, cells were pre-incubated with 2.26 mM
H-G-CCK8 peptide (100 fold excess with respect to PA
concentration) for 30 min followed by the addition of
FITC–PA aggregates and an additional incubation of 1 h.
3. Results and discussion
3.1 PA design, synthesis and aggregate formulation
The CCK8 peptide amphiphile (PA-[A]), reported in Scheme 1,
contains the CCK8 sequence, a glycine residue on the
N-terminus, three lysine residues and a hydrophobic moiety
with two C18 alkyl chains. The insertion of the three positively
charged lysine residues between the peptide portion and the
alkyl chains should induce an electrostatic repulsion eﬀect,
thus breaking the inter-peptide hydrogen bonds established
between the amino acid side chains during the aggregation
process. Actually, other charged amino acids, such as Glu or
Asp, could be used with the same aim. In this study, lysine
has been chosen because, at the physiological pH, the lysine
e-amino functions are protonated and the entire amphiphiles
result positively charged. As it is well known, cationic
aggregates are usually employed as gene delivery systems
due to their low toxicity and immunogenicity.32 The other
four CCK8 peptide amphiphiles (PA-[B]–PA-[E]) contain an
additional hexaoxahene linker. The presence of the hexa-
oxahene linker should help in the exposition of the bioactive
peptide sequence on the aggregate external surface. Moreover,
the idea to alternate the lysine residues with the linker allows
studying as to whether the positions of the positive charged
residues inﬂuence the peptide structure and its activity.
The CCK8 peptide modiﬁed with the glycine residue on the
N-terminus (H-G-CCK8) or with the glycine and three lysine
residues on the N-terminus (H-K-K-K-G-CCK8) have been
also synthesized for CD and ﬂuorescence comparative studies.
All the peptide derivatives were synthesized according to
standard solid-phase-peptide-synthesis protocols, using Fmoc/
tBu chemistry and Rink-amide MBHA resin as the polymeric
support.26 In the synthesis of amphiphilic peptides PA-[A]–PA-[E],
as already experienced with similar compounds,33 the
hexaoxahene linker and lysine residues were coupled, in solid
phase, by using the Fmoc-protected starting reagents
(Fmoc–Ahoh–OH and Fmoc–Lys(Boc)–OH), with a two-fold
and four-fold molar excess, respectively, and PyBop/HOBt/
DIPEA as activators. The hydrophobic N,N-dioctadecyl-
succinamic acid was eﬃciently coupled in solid-phase in a
DMF/DCM mixture. All the peptide derivatives were
collected in good yields after RP-HPLC chromatography
puriﬁcation. Analytical liquid chromatography and mass
spectrometry data (LC-MS and MALDI-TOF) conﬁrmed the
compound identities and their high purities. Notwithstanding,
variation of the position of the hexaoxahene linker in the
peptide sequence of PA-[B]–PA-[E] amphiphiles occurs,
the HPLC retention times do not change, signiﬁcantly.
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Self-assembled aggregates were prepared by simply dissolving
monomers in buﬀered solutions at diﬀerent pH values (5.0, 7.0,
12.0) at room temperature. C18H37CONHLys–(FITC)CONH2
(C18–FITC) ﬂuorescent probe was also synthesized in solid-
phase and crystallized by adding water drop-wise to the TFA
cleavage solution, and used without further puriﬁcation. The
b-alanine residue was introduced before the coupling step of
FITC chromophore to avoid ﬂuorescence elimination by the
Edman degradation mechanism.34 This product was also
characterized by NMR spectroscopy (1H and 13C). Fluorescent
aggregates of PA, containing 0.1% mol mol1 of C18–FITC
ﬂuorescent probe, were prepared for in vitro cellular uptake
assays. Incorporation of C18–FITC ﬂuorescent probe into PA
aggregates was monitored by gel ﬁltration using Sephadex G-50
pre-packed column.
3.2 Structural characterization
Dynamic Light Scattering measurements were performed on
PA aggregates in 10 mM HEPES buﬀer at pH 7.0. Aggregates
show a bimodal distribution, with well-separated modes. Both
modes are due to translational diﬀusion processes, which could
be attributed to two diﬀerent aggregate structures, with
apparent translational diﬀusion coeﬃcients Dfast and Dslow
(see Table 1). The Stokes–Einstein equation (1) is used to
evaluate the hydrodynamic radius, RH, at inﬁnite dilution
RH ¼ KBT
6pZD0
ð1Þ
where D0 is the translational diﬀusion coeﬃcient at inﬁnite
dilution, KB is the Boltzmann constant, T is the absolute
temperature, and Z is the solvent viscosity. Due to the high
solution dilution (C = 1  104 M) of the studied systems, we
have approximatelyDED0, and eqn (1) can be reasonable used
to estimate the hydrodynamic radius of the aggregates. The RH
values obtained for slow and fast modes, reported in Table 1, are
compatible with liposome and micelle structures, respectively.35
All liposome hydrodynamic radii range between 63.40 nm and
92.32 nm. On the other hand, the radii of the micelle aggregates
are between 4.2 and 12.3 nm. From a structural point of view,
these values are similar to those observed in systems we already
studied.33 In order to verify if the aggregate preparation
mode could inﬂuence the aggregate distribution in micelles
and liposomes, samples were also prepared according to well-
assessed sonication and extrusion procedures. DLS results
indicate a non-signiﬁcant deviation from data collected on
untreated samples (data not shown).
CMC values of micelle aggregates were determined by a
ﬂuorescence-based method using ANS as the probe.29,30 ANS
is weakly ﬂuorescent or non ﬂuorescent in water, but strongly
ﬂuorescent when bound to membranes in water. An increase in
probe ﬂuorescence intensity due to aggregate formation was
observed for all the studied samples. The ﬂuorescence intensities
at 480 nm, corresponding to the maximum of spectrum, on
function of the PA concentration are reported in Fig. 1 for
selected amphiphiles. CMC values of all samples determined by
the graphical break-points and reported in Table 1, range
between 9.70  106 and 2.53  105 mol kg1. The CMC
values of the new PA aggregates are higher with respect to the
CMC of (C18)2L5CCK8 (2.0  106 mol kg1), indicating
micelle destabilization due to the presence of positive charges
in these PA monomers. As expected, the destabilization eﬀect
increases as the positive charges are closer to the hydrophobic
moiety that drives the aggregation process.
3.3 Circular dichroism (CD) studies
The secondary peptide structure in PA aggregates was evaluated
by circular dichroism (CD) spectroscopy. CD studies (Fig. 2)
were carried out on samples at monomer concentration above
the CMC values. The CD spectra of PA-[C], PA-[D] and PA-[E]
indicate a random coil conformation of CCK8, similar to that
Table 1 Critical Micellar Concentration (CMC) values determined by ﬂuorescence and diﬀusion coeﬃcients and hydrodynamic radii obtained
from Dynamic Light Scattering measurements for the systems studied. The terms fast and slow refer to micelles and liposomes, respectively
Systems CMC/mol kg1 Dfast  1011/m2 s1 RH/nm Dslow  1012/m2 s1 RH/nm
PA-[A] 1.70  105 4.75  0.10 4.18  0.08 2.6  0.1 76.24  1.52
PA-[B] 9.70  106 n.m. n.m. 3.1  0.4 64.59  7.75
PA-[C] 1.17  105 4.42  0.13 4.50  0.13 3.1  0.1 63.40  3.80
PA-[D] 2.52  105 1.62  0.19 12.31  1.48 2.2  0.3 91.79  11.01
PA-[E] 2.53  105 2.97  0.45 6.70  0.44 2.2  0.3 92.32  4.45
Fig. 1 Fluorescence intensity of the ANS probe at 480 nm versus
amphiphiles concentration for micellar aggregates. Graphical break-
points indicate the CMC values. For clearness, only the curves
concerning PA-[C] and PA-[D] are reported. Similar behaviour is
found for the other amphiphilic compounds (see Table 1).
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found for H-G-CCK8, while PA-[A] and PA-[B] spectra show a
more deﬁned structural arrangement of the CCK peptide.
CD spectra were also carried out at diﬀerent pH values
(5.0, 7.0 and 12.0) in order to investigate how the protonation
grade of acid or basic residues inﬂuences the secondary
structure of the monomer (Fig. 2). Interestingly, an increase
of the peptide folding is observed for PA-[A] and PA-[B] as pH
increases, while variations in pH do not modify CD spectra of
PA-[C], PA-[D] and PA-[E].
The CD spectra suggest that in PA-[A] and PA-[B] amphi-
philes the three charged lysine residues, very close to the CCK8
peptide sequence, induce the peptide folding. This behaviour is
conﬁrmed by comparison with the conformational arrangement
of the reference compound H-K-K-K-G-CCK8. As reported
in Fig. 3, H-K-K-K-G-CCK8 peptide, in the presence of TFE (a
solvent widely used in conformational studies for its properties
to unmask peptides folding propensities), shows CD spectra
similar to that of PA-[A] and PA-[B].
Furthermore, PA-[A] and PA-[B] CD spectra look like the
reference compound H-G-CCK8 spectrum in the presence of
the membrane-like surfactant DPC (Fig. 4A).36 These results
suggest that both PA-[A] and PA-[B] peptides, adopt a
conformation similar to that found for the membrane-bound
CCK8: this indication allows us to hope that CCK8 peptide on
the external surface of PA-[A] and PA-[B] could be able to
interact with CCK receptors, delivering the entire aggregates
on the cellular target.
3.4 Fluorescence of tryptophan residue
A comparison between the ﬂuorescence behaviour of the
free H-G-CCK8 peptide in HEPES buﬀered water solution,
of H-G-CCK8 in the presence of DPC micelles, and of PA-[B]
aggregates is reported in Fig. 4B. PA-[A], PA-[C], PA-[D] and
PA-[E] show ﬂuorescence spectra super imposable with PA-[B]
and are omitted from Fig. 4B. This study aims to examine the
eﬀect of the diﬀerent solution conditions on the environment
of the tryptophan residue in the peptide sequence.
The spectra were collected on samples in which theH-G-CCK8
peptide concentration was 2  104 M, DPC concentration was
10 mM in 10 mMHEPES at pH 7.0, and spectra of PA-[B] were
collected at a monomer concentration of 2.0 104 M in 10 mM
Fig. 2 Far UV CD spectra of PA-[A]–PA-[E] supramolecular
aggregates at diﬀerent pH values; concentrations of amphiphilic
peptides are 2.0  104 M, higher than CMC values, to be certain of
the presence of aggregates in solution.
Fig. 3 CD spectra of H-K-K-K-G-CCK8 in HEPES buﬀered water
solution containing diﬀerent amounts of TFE (from 0 to 80%).
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HEPES at pH 7.0. The 2  104 M concentration used for all
systems investigated was chosen at the aim to assure that
amphiphilic monomers remain in their aggregate form. At this
concentration ﬂuorescence quenching phenomena could occur
and therefore any comparison between ﬂuorescence intensity can
be evaluated. On the other hand, ﬂuorescence wavelengths for the
indole moiety can be related to the tryptophan environment.
H-G-CCK8 in water solution and PA-[B] aggregates show
an emission maximum at 356 and 362 nm, respectively. These
wavelengths are diagnostic of the hydrophilic environment of
the indole group on tryptophan side-chain.37 Tryptophan
exposition on the aggregate surface suggests the
bioavailability of CCK8 peptide to the receptor binding site.
On the other hand, in the presence of DPC micelles, the
emission maximum for H-G-CCK8 is blue-shifted to 342 nm.
This wavelength is typical of a tryptophan contacting water
molecules of low mobility at the protein surface.
3.5 Flow cytometric analysis
The cell labelling eﬃciency of each PA formulation was
assessed by using ﬂow cytometry analysis based on FITC
ﬂuorescence. PA formulations were made ﬂuorescent by
insertion of a small amount of C18-FITC ﬂuorescent probe
into the aggregates. The previously reported aggregates based
on (C18)2L5CCK8 were also studied for comparative analysis.
Assays were performed on A431 cell line at 4 1C, in order to
block non-speciﬁc internalization; incubating cells with PA
ﬂuorescent aggregates for 1 h. Cells treated with unlabeled
aggregates were used as negative control. Binding results are
shown in Fig. 5. Fluorescent FITC-PA-[A] and FITC-PA-[B]
Fig. 4 (A) Plot of the CDmolecular ellipticity from 195 to 260 nm of H-G-CCK8 peptide in the presence of 10 mMDPCmicelle and of PA-[A] and
PA-[B] amphiphiles. (B) Plot of the ﬂuorescence emission spectra from 290 to 450 nm after excitation at 280 nm of H-G-CCK8 peptide in the
presence of 10 mM DPC micelle and of PA-[B] aggregates. CD and ﬂuorescence spectra of the free H-G-CCK8 are also reported for comparison.
Peptide concentration in all samples is 2.0  104 M; buﬀer is 10 mM HEPES at pH 7.0.
Fig. 5 Representative ﬂow cytometry histogram illustrating FITC-PA aggregates binding to A431 cells. A431 tumour cells (106 cells mL1) were
treated with 226 mM FITC-PA aggregates for 1 h at 4 1C. Cells treated with not ﬂuorescent PA-[C] were used as negative control. Measurements
were performed at least three times and typical result is showed.
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aggregates are found at higher ﬂuorescence values, while
FITC-(C18)2L5CCK8 is present at low ﬂuorescence values;
and FITC-PA-[C], FITC-PA-[D] and FITC-PA-[E] are found
in intermediate ﬁeld. This behaviour indicates that PA-[A] and
PA-[B] aggregates are a more eﬃcient cell-labelling vehicle
than PA-[C], PA-[D] and PA-[E]. On the other hand,
(C18)2L5CCK8 does not shown any eﬀective binding
properties towards A431 cells. Moreover, competitive binding
experiments on FITC-PA-[A] and FITC-PA-[B] were also
performed after pre-incubation of cells with a large excess of
H-G-CCK8, in order to demonstrate that the uptake is receptor
mediated. Results, reported in Table 2, were compared with the
binding behaviour of ﬂuorescent FITC-PA aggregates alone.
When the FITC-PA-[A] and FITC-PA-[B] ﬂuorescence is
monitored in the presence of the unlabeled H-G-CCK8, less
binding occurs, indicating a competition between the two ligands
for the receptor.
4. Conclusions
Supramolecular aggregates are obtained by self-aggregation
of cationic peptide amphiphiles in buﬀered water solution.
They have been characterized for peptide conformation and
bioavailability on the external aggregate surface, and for their
cell binding properties. The presence of CCK8 peptide
well-exposed on the aggregate surface has been assessed by
ﬂuorescence measurements. Anyway the peptide availability
on aggregates hydrophilic shell is not the unique requirement
for receptor binding: the peptide conformation is a fundamen-
tal task to assure high aﬃnity and selectivity in ligand/protein
binding processes. This is particularly true in the case of CCK8
peptide. CCK8 needs to assume a pseudo-a-helix conforma-
tion to give high aﬃnity interaction to the CCK1-R and
CCK2-R receptors, according to the membrane-bound path-
way theory. In fact, the supramolecular aggregates obtained by
self-aggregation of (C18)2L5CCK8, in which CCK8 peptide
is present in a b-sheet conformation, probably due to the
inter-peptide hydrogen bonds between amino acid side chains,
does not show in vitro cellular binding. Similar negative results
are observed for aggregates based on the cationic amphiphiles
PA-[C]–PA-[E]: the introduction of positive charges in
the amphiphilic monomers induces an electrostatic repulsion
between peptides giving a CCK8 unfolding process. Otherwise,
as clearly indicated by cytoﬂuorimetric studies, PA-[A] and
PA-[B] aggregates present promising binding properties to
CCK2-R receptors overexpressed by transfected A431 cells.
In these active aggregates, CCK8 peptide presents a structural
arrangement similar to that found for the same peptide in DPC
micelles: i.e. the peptide conformation required for receptor
binding. This conformational behaviour could be probably
induced by the presence of three charged lysine residues close
to the bioactive peptide sequence, as also supported by the
conformational behaviour of the reference compound H-K-K-
K-G-CCK8. Chemical modiﬁcations on the CCK8N-terminus
seem to play an important role in stabilizing the peptide active
conformation, either when the peptide derivative is in
monomer or in aggregate form. Supramolecular aggregates
based on PA-[A] and PA-[B] can be considered as promising
candidates for target selective drug carriers on cancer cells.
Abbreviations
PA peptide amphiphile
FITC Fluorescein 5-isothiocyanate
BSA bovine serum albumin
PBS phosphate buﬀered saline
DMEM Dulbecco eagle medium modiﬁed
FCS fetal calf serum
TFA triﬂuoroacetic acid
DLS Dynamic Light Scattering
DMF dimethylformamide
PyBop benzotriazol-1-yl-oxytris(pyrrolidino) phosphonium
HOBt 1-hydroxybenzotriazole
DIPEA N,N-diisopropylethylamine
DCM dichloromethane
Mtt 4-methyltrityl
TIS triisopropylsilane
HATU O-(7-azabenzotriazol-1-yl)-1,1,3,3-
tetramethyluronium
tBu tert-butyl
HBS 4-2-hydroxyethyl-piperazino-ethanesulfonic acid
CMC Critical micellar concentration
ANS 8-anilinonaphthalene-1-sulfonate
DPC dodecylphosphocholine
TFE triﬂuoroethanol
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